CCIA
DNLI icon

Campbell & Co Investment Adviser’s Denali Therapeutics DNLI Stock Holding History

Campbell & Co Investment Adviser’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-216,774
Closed -$3.15M – 1190
2025
Q3 		$3.15M Buy
216,774
+74,066
+52% +$1.06M 0.24% 92
2025
Q2 		$2M Buy
142,708
+74,523
+109% +$1.05M 0.13% 249
2025
Q1 		$927K Buy
68,185
+30,500
+81% +$584K 0.07% 461
2024
Q4 		$768K Buy
+37,685
New +$965K 0.06% 501
2024
Q1 		– Sell
-65,105
Closed -$1.4M – 1159
2023
Q4 		$1.4M Buy
65,105
+47,847
+277% +$948K 0.13% 243
2023
Q3 		$356K Buy
+17,258
New +$438K 0.04% 655
2023
Q2 		– Sell
-9,005
Closed -$207K – 943
2023
Q1 		$207K Buy
+9,005
New +$248K 0.04% 726

Other funds holding DNLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return